CStone Pharmaceuticals strikes $480m worth oncology deal with Pfizer
US pharma giant Pfizer has entered into a collaboration deal worth up to $480 million with Chinese biopharma…
Chinese biotech company InventisBio raises $147m in Series D round
InventisBio, a Chinese biotech company focused on small molecule drugs, has raised $147 million in a Series D…
XtalPi raises $319m for AI based drug research and development
XtalPi, a pharma company that leverages artificial intelligence (AI) for drug discovery and development, has raised $318.8 million…
Gilead, Galapagos bag Jyseleca EC approval for rheumatoid arthritis
Jyseleca EC approval : Gilead Sciences and Galapagos have secured marketing authorization for Jyseleca (filgotinib 200 mg and…
Galecto raises $64m to develop fibrosis and cancer treatments
Galecto, a Danish biotech company, has raised $64 million in an equity financing round, for developing novel treatments…
Novavax begins phase 3 trial of NVX-CoV2373 COVID-19 vaccine candidate
Novavax has initiated its first phase 3 clinical trial to assess the efficacy, safety, and immunogenicity of its…
GENFIT begins phase 3 trial of elafibranor in primary biliary cholangitis
GENFIT has started the phase 3 ELATIVE clinical trial for evaluating the efficacy and safety of elafibranor for…
OliX Pharmaceuticals seeks FDA nod for phase 2a trial of OLX10010
OliX Pharmaceuticals, a South Korean pharma company, has submitted an investigational new drug (IND) application to the US…
Millendo Therapeutics begins human trial of VMS drug candidate MLE-301
Millendo Therapeutics has started a phase 1 clinical trial of its selective neurokinin 3 receptor (NK3R) antagonist MLE-301,…
J&J begins phase 3 ENSEMBLE Covid-19 vaccine trial for JNJ-78436735
ENSEMBLE Covid-19 vaccine trial : Johnson & Johnson (J&J) has launched a multi-nation phase 3 trial called ENSEMBLE…